NextCure Correlations
NXTC Stock | USD 0.76 0.03 4.11% |
The current 90-days correlation between NextCure and Spero Therapeutics is 0.25 (i.e., Modest diversification). The correlation of NextCure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
NextCure Correlation With Market
Weak diversification
The correlation between NextCure and DJI is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NextCure and DJI in the same portfolio, assuming nothing else is changed.
NextCure |
Moving together with NextCure Stock
0.92 | FDMT | 4D Molecular Therapeutics | PairCorr |
0.75 | INVA | Innoviva | PairCorr |
0.86 | APVO | Aptevo Therapeutics | PairCorr |
0.8 | AMCCF | Amcor plc | PairCorr |
0.64 | ORGN | Origin Materials | PairCorr |
0.91 | HDVTY | Henderson Investment | PairCorr |
0.77 | UIS | Unisys Earnings Call This Week | PairCorr |
Moving against NextCure Stock
0.71 | DRTSW | Alpha Tau Medical | PairCorr |
0.56 | PFE | Pfizer Inc | PairCorr |
0.49 | GILD | Gilead Sciences | PairCorr |
0.46 | LNTH | Lantheus Holdings Earnings Call This Week | PairCorr |
0.44 | ABBV | AbbVie Inc | PairCorr |
0.77 | ANET | Arista Networks Earnings Call This Week | PairCorr |
0.74 | OKTA | Okta Inc | PairCorr |
0.69 | DUOT | Duos Technologies | PairCorr |
0.69 | WMT | Walmart Earnings Call This Week | PairCorr |
0.67 | META | Meta Platforms Aggressive Push | PairCorr |
0.64 | PLTR | Palantir Technologies Aggressive Push | PairCorr |
0.52 | TSLA | Tesla Inc Sell-off Trend | PairCorr |
0.39 | GS | Goldman Sachs Group | PairCorr |
0.31 | GPOVF | Grupo Carso SAB | PairCorr |
Related Correlations Analysis
0.6 | 0.0 | 0.27 | 0.66 | 0.64 | -0.6 | CTMX | ||
0.6 | 0.0 | 0.69 | 0.76 | 0.73 | -0.66 | SPRO | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | NLTX | ||
0.27 | 0.69 | 0.0 | 0.44 | 0.46 | -0.37 | TIL | ||
0.66 | 0.76 | 0.0 | 0.44 | 0.82 | -0.54 | ASMB | ||
0.64 | 0.73 | 0.0 | 0.46 | 0.82 | -0.56 | NUVB | ||
-0.6 | -0.66 | 0.0 | -0.37 | -0.54 | -0.56 | ACHL | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between NextCure Stock performing well and NextCure Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NextCure's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CTMX | 3.92 | (0.36) | 0.00 | (0.14) | 0.00 | 7.32 | 23.37 | |||
SPRO | 2.65 | (0.66) | 0.00 | (0.84) | 0.00 | 4.85 | 21.98 | |||
NLTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
TIL | 5.87 | (0.18) | 0.00 | (0.06) | 0.00 | 14.84 | 33.50 | |||
ASMB | 2.98 | (0.31) | 0.00 | (0.21) | 0.00 | 6.63 | 24.82 | |||
NUVB | 2.95 | (0.29) | 0.00 | (0.30) | 0.00 | 5.62 | 23.46 | |||
ACHL | 1.75 | 0.46 | 0.25 | 1.78 | 1.08 | 4.42 | 22.15 |
NextCure Corporate Management
CPA CPA | Chief Officer | Profile | |
Steven CPA | Chief Officer | Profile | |
Sebastien Maloveste | Senior Development | Profile | |
Sourav Kundu | Senior Manufacturing | Profile | |
Kevin Shaw | General Counsel | Profile | |
Michael MSBA | CEO, CoFounder | Profile | |
Lieping MD | CoFounder Board | Profile |